A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial (Q55981048)

From Wikidata

Jump to navigation Jump to search

article

edit

Language	Label	Description	Also known as
English	A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial	article

Statements

instance of

scholarly article

0 references

title

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial (English)

0 references

main subject

leukemia

1 reference

based on heuristic

inferred from title

author

Anthony H. Goldstone

series ordinal

3

object named as

Anthony H. Goldstone

0 references

author name string

Keith Wheatley

series ordinal

1

0 references

Alan K. Burnett

series ordinal

2

0 references

Richard G. Gray

series ordinal

4

0 references

Ian M. Hann

series ordinal

5

0 references

Christine J. Harrison

series ordinal

6

0 references

John K. H. Rees

series ordinal

7

0 references

Richard F. Stevens

series ordinal

8

0 references

Helen Walker

series ordinal

9

0 references

language of work or name

English

0 references

publication date

October 1999

0 references

published in

British Journal of Haematology

0 references

volume

107

0 references

issue

1

0 references

page(s)

69-79

0 references

cites work

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01684.X

retrieved

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01684.X

retrieved

21 January 2018

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01684.X

retrieved

21 January 2018

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01684.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2141.1999.01684.X

0 references

ResearchGate publication ID

229660395

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55981048&oldid=1982758616"